Targeting IL-15 in large granular lymphocyte leukemia

Expert Review of Clinical Immunology

Volumn 9, Issue 5, 2013, Pages 405-408

  Steinway, Steven N ^a   Loughran, Thomas P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

IL 15; large granular lymphocyte leukemia; Phase I clinical trial

Indexed keywords

ANTINEOPLASTIC AGENT; HU MIKBETA1; INTERLEUKIN 15; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); CONCENTRATION RESPONSE; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; NEUTROPHIL COUNT; NONHUMAN; THROMBOCYTE COUNT;

EID: 84877262819     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.13.28     Document Type: Article

References (16)

1. Zhang D, Loughran TP Jr. Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment. Hematology Am. Soc. Hematol. Educ. Program 2012, 652-659 (2012
2. Zhang R, Shah MV, Yang J et al. Network model of survival signaling in large granular lymphocyte leukemia. Proc. Natl Acad. Sci. USA 105(42), 16308-16313 (2008
3. Jerez A, Clemente MJ, Makishima H et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood 120(15), 3057 (2012
4. Shah MV, Zhang R, Irby R et al. Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood 112(3), 770-781 (2008
5. Epling-Burnette PK, Bai F, Wei S et al. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 23(57), 9229 (2004
6. Schade AE, Wlodarski MW, Maciejewski JP. Pathophysiology defined by altered signal transduction pathways: the role of JAK-STAT and PI3K signaling in leukemic large granular lymphocytes. Cell Cycle 5(22), 2571-2574 (2006
7. Loughran TP. Results of a prospective multicenter Phase II study of initial treatment with methotrexate in LGL leukemia (ECOG protocol E5998). Blood (ASH Annual Meeting Abstracts) 116(21).
8. Mohan SR, Clemente MJ, Afable M et al. Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia. Haematologica 94(10), 1414 (2009
9. Waldmann TA, Conlon KC, Stewart DM et al. Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-b-1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood 121(3), 476-484 (2013
10. Lodolce JP, Burkett PR, Koka RM, Boone DL, Aldo-Benson M.A. Regulation of lymphoid homeostasis by interleukin-15. Cytokine Growth Factor Rev. 13(6), 429-439 (2002
11. Chen J, Petrus M, Bamford R et al. Increased serum soluble IL-15Ra levels in T-cell large granular lymphocyte leukemia. Blood 119(1), 137-143 (2012
12. Azimi N, Nagai M, Jacobson S, Waldmann TA. IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc. Natl Acad. Sci. USA 98(25), 14559-14564 (2001
13. Morris JC, Janik JE, White JD et al. Preclinical and Phase I clinical trial of blockade of IL-15 using Mikb1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proc. Natl Acad. Sci. USA 103(2), 401-406 (2006
14. Hakimi J, Ha VC, Lin P et al. Humanized Mik b 1, a humanized antibody to the IL-2 receptor b-chain that acts synergistically with humanized anti-TAC. J. Immunol. 151(2), 1075-1085 (1993
15. Vidal JD, Drobatz LS, Holliday DF, Geiger LE, Thomas HC. Spontaneous findings in the heart of Mauritian-origin cynomolgus macaques (Macaca fascicularis). Toxicol. Pathol. 38(2), 297-302 (2010
16. Mishra A, Liu S, Sams GH et al. Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell 22(5), 645-655 (2012